BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2015
View Archived Issues
Cimzia begins phase III program for psoriasis
Read More
NIH signs agreement with Vtesse to develop treatments for Niemann-Pick disease type C
Read More
Bio Blast reports preliminary data from trial of Cabaletta in oculopharyngeal muscular dystrophy
Read More
Protalix reports interim data from phase I/II trial of PRX-102 for Fabry disease
Read More
Results from first phase III trial of Sativex for cancer pain
Read More
H&P Labs forms in-licensing agreement with Harvard University for Ebola treatment
Read More
Isarna files to begin clinical studies of ISTH-0036 for ophthalmic diseases
Read More
New TOPK-specific inhibitor induces tumor regression in xenograft model of lung cancer
Read More
Sangamo BioSciences in-licenses mRNA delivery technology
Read More
Biocept and Insight Genetics to advance NSCLC diagnostics
Read More
Horizon Discovery acquires Haplogen Genomics
Read More
Bone marrow hypoxia parallels leukemia progression
Read More
Novel hyperforin derivatives disclosed by Indena
Read More
Institute of Radiation Medicine divulges novel tyrosine kinase inhibitors for cancer
Read More
Karyopharm Therapeutics patents novel Exp1 inhibitors
Read More
MyoKardia prepares and tests new drugs for hypertrophic cardiomyopathy
Read More
Researchers in China present novel PARP-1 inhibitors
Read More
Helsinn Group obtains rights to license Monofer in the U.S.
Read More
FDA approves Duopa to treat motor fluctuations in advanced Parkinson's disease
Read More
GlyT1 inhibitor improves cognition and sociability in mouse model of ASD
Read More
China approves Epidaza for peripheral T-cell lymphoma
Read More
Phase III NSCLC trial stopped early after Opdivo shows superior overall survival to docetaxel
Read More
Biogen Idec to acquire Convergence Pharmaceuticals
Read More
Cornerstone initiates phase I study of CPI-613 for metastatic colorectal cancer
Read More
FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis
Read More